Recent advances in zinc oxide nanoparticles (ZnO NPs) for cancer diagnosis, target drug delivery, and treatment

S Anjum, M Hashim, SA Malik, M Khan, JM Lorenzo… - Cancers, 2021 - mdpi.com
Simple Summary Despite breakthroughs in medicine, cancer remains one of the most feared
diseases. Traditionally, chemotherapies have been the treatment of choice. However …

DNA damage/repair management in cancers

JF Alhmoud, JF Woolley… - Advances in Medical …, 2021 - api.taylorfrancis.com
DNA damage can alter nucleotide sequences and lead to expression of dysfunctional
proteins that impact normal cellular physiology. Sources of DNA damage can be …

[HTML][HTML] Battling chemoresistance in cancer: root causes and strategies to uproot them

A Ramos, S Sadeghi, H Tabatabaeian - International journal of molecular …, 2021 - mdpi.com
With nearly 10 million deaths, cancer is the leading cause of mortality worldwide. Along with
major key parameters that control cancer treatment management, such as diagnosis …

Technologies for circulating tumor cell separation from whole blood

P Bankó, SY Lee, V Nagygyörgy, M Zrínyi… - Journal of hematology & …, 2019 - Springer
The importance of early cancer diagnosis and improved cancer therapy has been clear for
years and has initiated worldwide research towards new possibilities in the care strategy of …

Reactive oxygen species and cancer: A complex interaction

S Saikolappan, B Kumar, G Shishodia, S Koul, HK Koul - Cancer letters, 2019 - Elsevier
Abstract Elevated levels of Reactive Oxygen Species (ROS), increased antioxidant ability
and the maintenance of redox homeostasis can cumulatively contribute to tumor progression …

[HTML][HTML] Cancer is a preventable disease that requires major lifestyle changes

P Anand, AB Kunnumakara, C Sundaram… - Pharmaceutical …, 2008 - Springer
This year, more than 1 million Americans and more than 10 million people worldwide are
expected to be diagnosed with cancer, a disease commonly believed to be preventable …

[HTML][HTML] Cancer as an evolutionary and ecological process

LMF Merlo, JW Pepper, BJ Reid, CC Maley - Nature reviews cancer, 2006 - nature.com
Neoplasms are microcosms of evolution. Within a neoplasm, a mosaic of mutant cells
compete for space and resources, evade predation by the immune system and can even …

Multiple mutations and cancer

LA Loeb, KR Loeb… - Proceedings of the …, 2003 - National Acad Sciences
Most human tumors are highly heterogenous. We have hypothesized that this heterogeneity
results from a mutator phenotype. Our premise is that normal mutation rates are insufficient …

[HTML][HTML] Human cancers express mutator phenotypes: origin, consequences and targeting

LA Loeb - Nature Reviews Cancer, 2011 - nature.com
Recent data on DNA sequencing of human tumours have established that cancer cells
contain thousands of mutations. These data support the concept that cancer cells express a …

A mutator phenotype in cancer

LA Loeb - Cancer research, 2001 - AACR
We have proposed that an early step in tumor progression is the expression of a mutator
phenotype resulting from mutations in genes that normally function in the maintenance of …